Selected Publications

2026

• Gabrio A (2026).“A Bayesian modelling framework for health care resource use and costs in trial-based economic evaluations”, Medical Decision Making, 46(2), 158-173.

• Schouten TJ, Gabrio A, Cals JW, Spigt M (2026).“A practical application for the efficient use of historical data in randomized controlled design using systematic review data”, Clinical Trials.

• van de Koolwijk AF, Gabrio A, Delnoij TS, Suverein MM, Eussen SE, Essers BA, Oude Lansink-Hartgring A, Hermanides RC, Otterspoor LC, Elzo Kraemer CV, Vlaar AP (2026). “Cost-effectiveness of extracorporeal CPR for out-of-hospital cardiac arrest: a trial-based Markov model with a lifetime horizon.”EuropeanHeartJournal:AcuteCardiovascularCare 15(7), 516-523.

• van der Broeck LCA, Shchurov DG, Gabrio A, Lodewijks AJL, Poeze M, Blokhuis TJ, Evers S (2026). “The economic burden in terms of cost of illness and generic health-related quality of life of posttraumatic long bone non-unions among the adult population of the Netherlands from a societal perspective.”EuropeanJournalofTraumaandEmergencySurgery 52(1), 183.

2025

• Gabrio A, Gomes M, Mason AJ, Leurent B (2025). “R for Health Technology Assessment ” (chapter: Missing Data), Boca Raton, FL: CRC Press, 137-167.

• Ling X, Gabrio A, Baio G (2025). “Bayesian Cost-Effectiveness Analysis Using Individual-Level Data is Sensitive to the Choice of Uniform Priors on the Standard Deviations for Costs in Log-Normal Models. ”PharmacoEconomics 43(11), 1309-1321.

• Pustjens TS, Veenstra L, Camaro C, Ruiters AW, Lux A, Ruzsa Z, Piroth Z, Ilhan M, Vainer J, Gho B, Winkler PJC, Stein M, Theunissen RALJ, Kala P, Polad J, Berta B, Gabrio A, van Royen NM van ‘t Hof AVJ, Rasoul S (2025). “Fractional flow reserve-guided complete vs culprit-only revascularization in non-ST-elevation myocardial infarction and multivessel disease: the SLIM randomized clinical trial. ”JAMA 334(18), 1628-1637.

• Frissen L, Aarts S, Rosteius K, de Boer B, Gabrio A, Verbeek H (2025). “The influence of social interactions on mood in residents with dementia in green care farms: An observational study using ecological momentary assessments”, International Psychogeriatrics.

2024

• Rosteius K, Frissen L, de Boer B, Gabrio A, Verbeek H (2024). Exploring the activating effects of the care environment of green care farms for people with dementia, Innovation in Aging, 8(Suppl 1), 624.

• Brouwers M, de Boer B, Groen W, Gabrio A, Verbeek H, Hamers J, Groen W, Gabrio A, Verbeek H (2024). Depressive Signs and Daily Life of Residents When Relocating from a Regular to an Innovative Nursing Home, Journal of the American Medical Directors Association, 25(12), 105298.

• Heuts S, Kawczynski M, Sayed A, Urbut S, Albuquerque A, Mandrola J, Kaul S, Harrell F, Gabrio A, Brophy, J (2024). Bayesian analytical methods in cardiovascular clinical trials: Why, when, and how, Canadian Journal of Cardiology.

• Heuts S, Ubben J, Kawczynski M, Gabrio A, Suverein M, Delnoij T, Kavalkova P, Rob D, Komárek A, van der Horst I, Maessen J, Yannopoulos D, Belohlavek J, Lorusso R, van de Poll, M (2024). Extracorporeal cardiopulmonary resuscitation versus standard treatment for refractory out-of-hospital cardiac arrest: a Bayesian meta-analysis, Critical Care, 28(1), 217.

• Albakri U, Smeets N, Drotos E, Kant I, Gabrio A, Meertens R (2024). Sleep quality and the need for recovery among nurses working irregular shifts: A cross-sectional study, Work, (Preprint), 1-14.

2023

• I Wiethoff, M Sikking, S Evers, A Gabrio, M Henkens, M Michels, J Verdonschot, S Heymans, M Hiligsmann (2023). Quality of life and societal costs in patients with dilated cardiomyopathy, European Heart Journal-Quality of Care and Clinical Outcomes.

• L Koeser, F Rost, A Gabrio, T Booker, D Taylor, P Fonagy, D Goldberg, M Knapp, P McCrone (2023). Cost-effectiveness of long-term psychoanalytic psychotherapy for treatment-resistant depression: RCT evidence from the Tavistock Adult Depression Study (TADS), Journal of Affective Disorders, 335, 313-321.

• Gabrio A (2023). A review of heath economic evaluation practice in the Netherlands: are we moving forward ?,  Health Economics, Policy and Law, 1-18.

• Koeser L, Rost F, Gabrio A, Booker T, Taylor D, Fonagy P, Goldberg David, Knapp Martin, McCrone Paul (2023). Cost-effectiveness of long-term psychoanalytic psychotherapy for treatment resistant depression: RCT evidence from the Tavistock Adult Depression Study (TADS), Journal of Affective Disorders, 335, 313-321.

2022

• Lohan M, Brennan-Wilson A, Hunter R, Gabrio A, McDaid L, Young H, French R, Aventin A, Clarke M, McDowell C, Logan D, Toase S, O’Hare L, Bonell C, Gillespie K, Gough A, Lagdon S, Warren E, Buckley K, Lewis R, Adara L, McShane T, Bailey J, White J (2022). Effects of gender-transformative relationships and sexuality education to reduce adolescent pregnancy (The JACK trial): a cluster randomised trial, The Lancet Public Health, 7(7), E626-E637.

• Gabrio A, Gunsoy N, Baio G, Martin A, Paly V, Risebrough N, et al. (2022). Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modelling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT trial. International Journal of Chronic Obstructive Pulmonary Disease, 1633-1642. 

• Gabrio A, Plumpton C, Banerjee S, Leurent B (2022). Linear mixed models to handle missing at random data in trial-based economic evaluations, Health Economics, 31(6), 1276-1287.

• Ling X, Gabrio A, Mason AJ, Baio G (2022).  A scoping review of item-level missing data in within-trial cost-effectiveness analysis. Value in Health - pre-print version.

2021

• Rooijackers TH, Metzelthin SF, van Rossum E, Kempen GIJM, Evers SMAA, Gabrio A, Zijlstra GAR (2021). Economic Evaluation of a Reablement Training Program for Homecare Staff Targeting Sedentary Behavior in Community-Dwelling Older Adults Compared to Usual Care: A Cluster Randomized. Controlled Trial. Clin Interv Aging: 16:2095-2109

• Gabrio, A. (2021).  A Bayesian framework for patient-level partitioned survival cost-utility analysis. Medical Decision Making: 41(8), 1033-1048.

• Gabrio, A., Hunter, R., Mason, J.M., Baio, G. (2021).  Joint longitudinal models for dealing with missing at random data in trial-based economic evaluations . Value in Health: 24(5), 699-706. 

2020

• Clarke, C., Brawley, C., Ingleby, F., Gabrio, A., Dearnaley, D., Matheson, D., Attard, G., Rush, H., Jones, R., Clarke, N., Parmar, M., Sydes, M., Hunter, R., James, N. (2020). Addition of abiraterone to first-line long-term hormone therapy in prostate cancer (STAMPEDE): Model to estimate long-term survival, quality-adjusted survival, and cost-effectiveness. Journal of Clinical Oncology: 38(2): 204.

• Gabrio, A. 2020. Bayesian Hierarchical Models for the Prediction of Volleyball Results. Journal of Applied Statistics : 1-21, 2020.

• Gabrio, A., Daniels, J.M., Baio, G. 2020.  A Bayesian Parametric Approach to Handle Missing Longitudinal Outcome Data in Trial-Based Health Economic Evaluations. Journal of the Royal Statistical Society, Series A: 183(2): 607-29. 

2019

• Gabrio, A; Baio, G; and Manca. Bayesian Statistical Economic Evaluation Methods for Health Technology Assessment. In Oxford Research Encyclopedia of Economics and Finance . Oxford University Press, Oxford, UK, 2019.

• Gabrio, A., Mason, J.M., Baio, G. 2019. A Full Bayesian Model to Handle Structural Ones and Missingness in Economic Evaluations from Individual-Level Data . Statistics in Medicine: 38(8): 1399-1420 .

2017

• Gabrio, A., Mason, J.M., Baio, G. 2017. Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: a Review with Future Recommendations. PharmacoEconomics-Open 1(2): 79-97